Carol Giltner Gallagher - Nov 13, 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Nov 13, 2023
Transactions value $
$68,214
Form type
4
Date filed
11/15/2023, 05:07 PM
Previous filing
Jun 23, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Purchase $40K +179K +94.51% $0.22* 368K Nov 13, 2023 Direct F1
transaction ATRA Common Stock Purchase $28.2K +91K +24.69% $0.31* 459K Nov 14, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.205 to $0.251. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.
F2 Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2862 to $0.3229.